The Lytic Cycle

A lytic infection is a productive viral infection cycle that culminates in the death (lysis) of the host cell and the release of progeny virus particles. It contrasts with a lysogenic infection, in which the phage genome is maintained quiescently, often integrated into the host chromosome as a prophage, without killing the cell. Phages capable of only the lytic pathway are called virulent phages (bacteriophage T4 is the classic example); phages capable of choosing between lytic and lysogenic fates are temperate phages (bacteriophage λ is the classic example). The lytic cycle unfolds in five recognizable stages: adsorption (the phage recognizes and binds a specific host-surface receptor), penetration (the viral genome is injected into the cytoplasm while the capsid remains outside), biosynthesis (the host's transcription, translation, and replication machinery is redirected to make viral components), maturation/assembly (structural proteins self-assemble into new virions and package the replicated genome), and lysis (the host cell envelope is breached, releasing progeny). The number of new virions released per infected cell is the burst size, and the time from infection to lysis is the latent period — two quantities that define the reproductive efficiency of a phage the way clutch size and gestation time define an animal's reproductive strategy. A key conceptual point, established across decades of molecular virology, is that biosynthesis is not a single undifferentiated burst of viral gene expression. Instead it proceeds as a cascade of temporal classes of genes — early, middle, and late in phage T4's terminology (immediate-early, delayed-early, and late in phage λ's) — in which each class's protein products create the conditions required to transcribe the next class. This cascade ensures that structural proteins and lysis enzymes, which would be useless or destructive if made too soon, appear only after the genome has been replicated many times over.

Adsorption. The phage's tail fibers (or, in tailless phages, capsid proteins) recognize a specific receptor on the bacterial cell surface — an outer-membrane protein, a lipopolysaccharide component, a pilus, or a flagellum, depending on the phage. Binding is reversible at first (electrostatic, low-affinity contact) and becomes irreversible once the baseplate or tail-tip proteins engage the receptor with high specificity, a step already covered under Bacteriophages and Host Recognition. This specificity is the molecular basis of a phage's narrow host range and is exploited therapeutically to target particular pathogens without harming commensal flora.

Penetration. For tailed phages such as T4, the baseplate undergoes a conformational change upon receptor engagement: the sheath contracts around the tail tube (much like a syringe plunger), driving the tube through the outer membrane, periplasm, and peptidoglycan layer. Phage-encoded lysozyme-like enzymes carried in the tail locally digest the peptidoglycan to permit passage. The tail tube then fuses with the inner membrane, and the linear double-stranded DNA genome is ejected into the cytoplasm — pushed partly by internal capsid pressure (which can reach tens of atmospheres) and partly pulled in by the cell's own DNA-translocation machinery. The empty capsid ("ghost") remains outside; a key demonstration of this fact is one of the most famous experiments in molecular biology (below).

Biosynthesis — the temporal cascade. Once inside, the phage genome is transcribed by the host's own RNA polymerase initially, since no other machinery yet exists. Three overlapping temporal classes follow:

• Early genes are transcribed almost immediately using host RNA polymerase recognizing phage promoters. Their products typically shut down host transcription and degrade the host chromosome (in T4, an early gene product degrades host DNA to supply nucleotides for phage DNA synthesis while sparing phage DNA, which carries a modified base, hydroxymethylcytosine, that resists this nuclease), and they begin assembling the phage DNA replication apparatus.
• Middle genes encode enzymes for phage DNA replication (a phage-specific DNA polymerase, primase, helicase, single-strand binding proteins) and, in many phages, a modified RNA polymerase subunit or a new sigma-like factor that redirects transcription specificity toward middle and late promoters.
• Late genes are transcribed only after DNA replication has begun — often because the replicating DNA itself creates the template structure late promoters require — and encode capsid, tail, and tail-fiber structural proteins, the packaging (terminase) machinery, and the lysis proteins.

This cascade means that structural and lytic genes are physically incapable of being expressed until dozens to hundreds of genome copies already exist, maximizing the number of progeny that can be built from one infection.

Assembly (maturation). New virions do not simply crystallize into being; they are built through an ordered pathway of subassembly, much like a factory with parallel assembly lines that converge at the end. In phage T4 this was worked out in extraordinary detail: 1. Major capsid protein (gene product 23) polymerizes around a scaffolding protein core to form a prohead. 2. The scaffold is proteolytically removed and the prohead expands and stabilizes. 3. Concatemeric replicated DNA (long head-to-tail repeats produced by rolling-circle-like replication) is threaded into the head by an ATP-driven terminase/portal motor, which also cuts the DNA to package one genome-length per head — one of the most powerful molecular motors known, generating forces of tens of piconewtons. 4. Separately, tail components (baseplate, tail tube, contractile sheath) self-assemble in their own pathway. 5. Tail fibers assemble independently and attach last. 6. The completed head, tail, and fibers join to form the mature, infectious virion.

Lysis. Release of progeny is itself a controlled, genetically timed event, not simply osmotic rupture from overcrowding. Two protein classes carry it out:

• Holins are small phage-encoded membrane proteins that accumulate harmlessly in the inner (cytoplasmic) membrane until they reach a genetically programmed threshold concentration/time, at which point they suddenly oligomerize and form large lesions ("holes") in the membrane.
• Endolysins (phage-encoded peptidoglycan hydrolases, e.g., lysozyme-like muramidases) are synthesized earlier but trapped in the cytoplasm, unable to reach their substrate (the peptidoglycan in the periplasm) until holin action breaches the membrane. Once endolysin reaches the cell wall, it degrades peptidoglycan rapidly, and turgor pressure ruptures the weakened cell, releasing progeny virions.

This two-component "molecular clock" (holin timing + endolysin action) explains why lysis occurs abruptly at a genetically determined time rather than gradually — an insight now exploited in engineering phage-derived enzymes ("lysins") as antibacterial agents.

The Hershey–Chase experiment (1952) proved that DNA, not protein, is the genetic material injected during penetration. Alfred Hershey and Martha Chase worked with bacteriophage T2 infecting E. coli. They separately labeled the protein coat with radioactive sulfur (³⁵S, since sulfur occurs in protein but not DNA) and the DNA core with radioactive phosphorus (³²P, since phosphorus is abundant in DNA's backbone but nearly absent from protein). After allowing infection to proceed briefly, they agitated the mixture in a kitchen blender to shear off the phage "ghosts" (empty capsids) from the bacterial cell surface, then centrifuged the bacteria into a pellet. They found that most of the ³²P (DNA label) pelleted with the bacteria, while most of the ³⁵S (protein label) stayed in the supernatant with the empty capsids. Progeny phage produced from the infected bacteria contained very little ³⁵S but substantial ³²P. This showed that the phage genome — DNA — enters the cell and directs the production of new phage, while the protein coat is left behind outside, confirming DNA (not protein) as the hereditary material and directly demonstrating the penetration mechanism described above.

The one-step growth experiment (Ellis and Delbrück, 1939) established the quantitative kinetics of the entire lytic cycle and introduced the concepts of latent period and burst size that define productive infection. Max Delbrück and Emory Ellis infected a bacterial culture with phage at a low multiplicity of infection (MOI, phage-to-bacteria ratio, kept well below 1 to ensure most infected cells receive only a single phage) and then diluted the mixture enormously to prevent any further adsorption of free phage to uninfected cells. They sampled the culture at short time intervals and measured the number of infectious phage particles (by plaque assay) at each time point. The resulting curve has a characteristic shape:

Crucially, if infected cells are artificially lysed early (by chloroform or lysozyme treatment) partway through the latent period, few or no completed phage are found — proving that phage assembly is genuinely gradual and intracellular, not instantaneous, and that the eclipse period (during which no infectious phage exist even inside the cell) precedes a later maturation phase in which completed particles accumulate. Dividing the final plateau titer by the initial number of infected cells gives the burst size, typically 50–200 virions per cell for T4 under standard laboratory conditions, though this varies by phage and by growth conditions (richer media and faster host growth generally support larger bursts).

In vitro complementation experiments by William Wood and R.S. Edgar (1960s) proved that phage assembly is a genetically ordered, stepwise pathway rather than spontaneous self-organization from a pool of parts. Using collections of conditional (temperature-sensitive and amber) mutants of T4, each defective in a single assembly gene, they showed that extracts from cells infected with two different mutants — each individually unable to make complete phage — could be mixed in vitro and would spontaneously complete assembly into infectious particles, because each extract supplied the missing component the other lacked. By systematically mixing pairs of mutant extracts and observing which combinations restored infectivity, they reconstructed the entire assembly pathway (heads, tails, and tail fibers as separate sub-lines that join only at defined late steps), turning "self-assembly" from a vague idea into a mapped biochemical pathway with a defined order of operations.

Example 1 — calculating burst size and total yield from one-step growth data. A culture of 2.0 × 10⁷ CFU/mL E. coli is mixed with phage T4 at MOI = 0.1 (so most infected cells receive one phage). After adsorption, unadsorbed phage are removed and the mixture is diluted 1:1000 to block further infection. Plaque assays over the next 40 minutes give:

Number of cells originally infected = MOI × bacterial density = 0.1 × 2.0 × 10⁷ = 2.0 × 10⁶ infected cells/mL (before the 1000-fold dilution; after dilution this is 2.0 × 10³ infected cells/mL, matching the background titer scale used above for comparison). Final titer at plateau = 2.0 × 10⁵ PFU/mL. Burst size = (final titer − background) / (number of infected cells) = (2.0 × 10⁵ − 2.0 × 10³) / 2.0 × 10³ ≈ 99. So each infected cell released roughly 99 progeny virions, and the latent period (time from infection to the start of the rise, here the interval ending near 25–30 minutes) is about 25–28 minutes under these conditions — consistent with T4's typical laboratory latent period of roughly 20–25 minutes and burst size of order 100.

Example 2 — reasoning through an MOI and lysogeny-avoidance scenario in phage therapy. A clinical microbiologist is designing a phage cocktail against a wound infection caused by Pseudomonas aeruginosa at a density of 10⁸ CFU/mL. The available phage stock is a virulent (obligately lytic) phage titered at 10¹⁰ PFU/mL. The clinician wants to ensure a high enough MOI that essentially all bacteria are infected promptly (since sub-lethal, low-MOI dosing risks selecting for phage-resistant survivors), while remembering that virulent phages, unlike temperate ones, cannot enter lysogeny even at high MOI — an important safety property. If the clinician applies phage at a 10-fold dilution from stock (final titer 10⁹ PFU/mL) to the wound bed already containing 10⁸ CFU/mL of bacteria, the effective MOI is: MOI = phage titer / bacterial titer = 10⁹ / 10⁸ = 10. At MOI = 10, essentially every bacterial cell (following Poisson statistics, the fraction of cells receiving zero phage is e⁻¹⁰ ≈ 0.0000454, i.e., under 0.005%) is expected to be infected, minimizing the pool of uninfected survivors that could regrow and driving the population toward rapid, near-total lysis within one latent period (roughly 20–40 minutes for a fast-lysis Pseudomonas phage). This calculation — reasoning from titer ratios to Poisson infection probability — is exactly the kind of dosing logic used in designing effective phage therapeutics, and it depends critically on the phage chosen being strictly lytic, since a temperate phage at high MOI can instead be driven toward lysogeny (a phenomenon foreshadowed by the lysogenic decision-making machinery covered separately).

Max Delbrück trained originally as a theoretical physicist in Germany before turning to biology in the 1930s, convinced that the precision of physical law might be found lurking beneath the apparent chaos of heredity. He emigrated to the United States and, working with bacteriophages as a stripped-down, mathematically tractable model system, co-founded what became known as the American Phage Group, a loose collaborative network (including Salvador Luria and Alfred Hershey) that treated phage infection almost as an experiment in applied physics: countable particles, discrete events, reproducible kinetics. Delbrück's insistence on quantitative, single-event resolution — rather than studying bulk, asynchronous bacterial cultures — is what made the one-step growth curve conceptually possible: by synchronizing infection and blocking secondary rounds of adsorption, he and Emory Ellis converted a messy population process into a clean, countable time course.

The lytic cycle is not a historical curiosity; it is the direct basis of phage therapy, the therapeutic use of lytic bacteriophages to treat bacterial infections, including multidrug-resistant strains where conventional antibiotics have failed. Because virulent phages cannot lysogenize, they are strongly preferred as therapeutic agents (avoiding the risk of establishing a stable, potentially gene-transferring prophage). Phage-encoded endolysins are themselves being purified and developed as standalone antibacterial enzymes ("enzybiotics"), since a purified endolysin applied externally to Gram-positive bacteria (whose peptidoglycan is exposed) can lyse cells directly without needing an intact infection cycle. Understanding the terminase/portal DNA-packaging motor, one of the most powerful molecular motors characterized to date, has informed biophysical models of molecular force generation and inspired synthetic-biology efforts to repurpose viral packaging machinery for nanotechnology, including DNA/RNA nanoparticle delivery systems. In agriculture and food safety, lytic phage cocktails are used to control pathogens like Salmonella and Listeria on food surfaces and in processing plants. Finally, the temporal-cascade logic discovered in phage biosynthesis (early genes enabling middle and late genes) turned out to be a recurring theme across virology broadly, informing how researchers study gene-expression timing in far more complex viruses, and it sets up the crucial comparison to come: the Lysogenic Cycle, in which this entire lytic program is instead suppressed, and the pursuit of drugs that interrupt specific stages of this cycle, covered under Antiviral Strategies and Drug Targets, along with the receptor-recognition step introduced in Bacteriophages and Host Recognition.

Ask the tutor: How does the lysis/lysogeny decision get made molecularly in a temperate phage like λ, and what tips the switch one way or the other?